March 2024 - Page 4 of 5 - CannabisNewsWire

FridayMar 08, 2024 4:20 pm

420 with CNW — Virginia Lawmakers Pass Cannabis Sales Bill, Send to Governor

Virginia lawmakers have recently given their final nod to legislation aiming to legalize the retail sale of cannabis, slated to commence from May 1, 2025. This decision, following several weeks of negotiations, now awaits the approval of Governor Glenn Youngkin. Both the Senate and House of Delegates endorsed similar versions of the measures on Feb. 28, 2024, reconciling differences after amendments from a committee in the Senate threatened to disrupt the agreement between the two chambers. Later, each chamber approved the bills from the other, forwarding them to the governor for potential enactment. A prior Democratic-led measure from 2021 allowed…

FridayMar 08, 2024 9:30 am

Could Marijuana Hold Key to Addressing Pain Related to Aging?

Marijuana contains more than 100 compounds, the major ones being tetrahydrocannabinol (THC) and cannabidiol (CBD). Of the two primary compounds, THC induces a high when consumed while CBD does not. Research has found that some of marijuana’s compounds safeguard the brain’s neurons. Some of marijuana’s antioxidant properties can also fight oxidative stress, which influences aging. Oxidative stress refers to a disruption in the balance between antioxidant defenses and the production of free radicals in the body. With regard to aging, age-related decreases in physiologic functions are caused by an accumulation of oxidative damage to macromolecules. This, researchers believe, increases with…

FridayMar 08, 2024 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Banking on DehydraTECH(TM) Technology for Major 2024 Growth

Lexaria, a global innovator in drug delivery platforms, has, since 2016, proven its patented DehydraTECH(TM) technology, asserting its superiority in improving drug bioavailability This has earned it 39 granted patents, with many pending globally DehydraTECH has a number of potential pharmaceutical applications with successful early stage results in hypertension, diabetes and weight loss and many others With its focus on GLP-1 clinical studies for 2024, Lexaria looks to carve out greater market share to make 2024 its biggest year Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has been pushing the envelope and redefining drug delivery technology.…

ThursdayMar 07, 2024 4:20 pm

420 with CNW — Veterans Groups Urge Biden Administration to Reclassify Cannabis

Leading U.S. veterans’ organizations are urging the Biden administration to promptly relax federal marijuana laws, aligning with a growing chorus of voices advocating for rescheduling the substance six months after a recommendation from the U.S. Department of Health and Human Services (HHS). Expressing their sentiments in a recent letter, the groups have called upon the Department of Justice, which oversees the U.S. Drug Enforcement Administration (DEA), to take swift action. Highlighting the challenges faced by veterans of the United States Armed Forces when they return home, the coalition, comprising entities such as the Minority Veterans of America, AMVETS, Iraq and…

WednesdayMar 06, 2024 4:20 pm

420 with CNW — Company Makes First Export of DEA-Approved Marijuana from Jamaica to US

A Jamaican-Canadian company based in Toronto and formed by Canopy Growth Corp. and Steep Hill Labs’ former employees, has completed what it asserts to be the inaugural DEA-approved export of marijuana products from Jamaica to the United States. The company, Pure Jamaican, alongside Seven-10 Pharmaceuticals, its manufacturing and cultivation division located in Montego Bay, Jamaica, dispatched a range of eight distinct tincture products and three diverse distillate products containing varying ratios of CBD and THC, according to Scott Cathcart, who heads both entities. Only a small batch of the products was sent for DEA-sanctioned research purposes. The products were shipped…

WednesdayMar 06, 2024 11:15 am

Four States Want Female Orgasmic Disorder Added to Medical Cannabis Qualifying Conditions List

A number of states in the United States are on course to adding female orgasmic disorder to a list of conditions that qualify for medical cannabis. Supporters have cited various studies that have demonstrated how marijuana can significantly improve orgasmic ease, satisfaction and frequency in individuals with female orgasmic disorder. Female orgasmic disorder is characterized by a delay in or lack of sexual climax despite sexual arousal and sufficient sexual stimulation. Among the states working on this initiative is Ohio, whose medical board announced that female orgasmic disorder and autism spectrum disorder would be forwarded for review and public commentary…

TuesdayMar 05, 2024 4:20 pm

420 with CNW — Maryland Legislators Consider Bills Against Workplace Discrimination for Cannabis Users

Legislative committees in Maryland’s state House of Delegates and Senate convened last week to deliberate on proposed measures aimed at shielding workers from repercussions due to off-duty marijuana use. The bills’ essence lies in shifting the burden of proof onto employers, requiring them to demonstrate on-the-job impairment before taking disciplinary action against an employee. Introduced as SB 513 by Senator Alonzo Washington and as HB 525 by Delegate Jheanelle Wilkins, both bills share near-identical language. The Finance Committee in the Senate heard testimonies on SB 513 on Thursday, while the House’s Economic Matters Committee followed suit with HB 525 a…

MondayMar 04, 2024 4:20 pm

420 with CNW — Official Records Show Recreational Marijuana Sales in Canada Exceeded C$5B in 2023

In 2023, Canada’s recreational marijuana market boasted a value of approximately C%5.07 billion ($3.8 billion), a recent government report on retail sales stated. This reflects a 12.2% increase from the previous year, showcasing a trend of growth, albeit at a slower pace compared to earlier years, marking more than five years since the legalization of recreational marijuana in 2018. Brad Poulos, an entrepreneurship professor at Toronto Metropolitan University, explains this slowdown as a normal evolution of the market. He points out that a big part of the increase in sales of legal marijuana comes from customers moving away from illegal…

MondayMar 04, 2024 10:30 am

Study Shows CBD-Dominant Marijuana Products Can Ease Anxiety While Negating Risks of THC

A new study has found that marijuana products dominant in CBD can ease anxiety more effectively in comparison to products that contain THC. THC and CBD are the two primary compounds found in marijuana. However, unlike CBD, THC induces a high when ingested. The study was carried out by researchers at CU Boulder. It is the first randomized trial to investigate how commercially available marijuana influences symptoms of anxiety. Currently, one in five adults in America have an anxiety disorder, which makes it a common mental health condition in the United States. The researchers’ primary objective was to better understand…

MondayMar 04, 2024 9:45 am

Zoned Properties Inc. (ZDPY) Is ‘One to Watch’

Zoned Properties in January 2024 acquired an investment property in Chicago and signed a long-term lease agreement for Justice Cannabis Co. to operate a retail dispensary there The company reported revenues of $720,450 for the quarter ended September 30, 2023, compared to $614,988 for the same quarter in 2022, an increase of 17.2% Zoned Properties reported net income of $114,523 for the September 2023 quarter, compared to a net loss of $77,328 for the same quarter a year earlier The company continues to build out its proprietary cannabis technology platform, REZONE, in preparation for commercial launch Zoned Properties in August…